毕业于北京师范大学，2020年11月入职脑院，在协和药物所从事新药研发长达6年，在新药的设计、合成以及计算机模拟等方面的工作，发表相关论文10余篇，如：Angew. Chem. Int. Edit., Org. Lett., Chem. Commun., Bioorg. Med. Chem. Lett.。 曾主持中国医学科学院药物研究所-创新药物发现与新技术专项基金1项(2014CX01)，参与多项国家重大项目。
代表成果
1. Chen Hualong#; Liu Yajing#; Cheng Xuebo; Fang Senbiao; Sun Yuli; Yang Zequn; Zheng Wei; Ji Xunming*; Wu Zehui*; Self-Assembly of Size-Controlled m-Pyridine-Urea Oligomers and Their Biomimetic Chloride Ion Channels, Angew. Chem. Int. Ed. 2021, 60, 2-11. 2. Liu Yajing; Chi Chenjing; Wu Renbo; Huang Yong; Liu Song; Sun Mingyue; Sun Yuli; Yang Zequn; Chen Hualong*; Wu Zehui*; A new class of meta-pyridine-urea oligomers for selective identification of mercury(II) ions, Tetrahedron Letters, 2019 (60), 1671-1674. 3. Chen Hualong; Guo Zhifo; Lu Zhonglin*; Controlling Ion-Sensing Specificity of N-Amidothioureas: From Anion-Selective Sensors to Highly Zn2+-Selective Sensors by Tuning Electronic Effects, Organic Letters, 2012, 14 (19), 5070-5073. 4. Cui Guonan; Jin Jing; Chen Hualong; Cao Ran; Chen Xiaoguang*; Xu Bailing*; Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors, Bioorganic & Medicinal Chemistry, 2018, 26(8), 2186-2197.
